Prucalopride May Help Clear Depression-Related Brain Fog
An existing constipation drug has shown promise in improving cognitive function in individuals with a history of depression.
Researchers investigated the potential benefits of prucalopride in a small clinical trial. The medication, typically used to treat constipation, targets a serotonin receptor found in both the gut and the brain. This study aimed to explore its effects on cognitive function in individuals with a history of depression. A week-long treatment with prucalopride was compared to a placebo in a small group of participants. The results suggest that prucalopride may improve memory, attention, and thinking speed in those with depression-related brain fog. Notably, the treatment was well-tolerated, with no significant side effects observed. Further studies are needed to confirm these findings and explore the potential therapeutic applications of prucalopride in this context. The potential mechanism by which prucalopride exerts its effects on the brain is not fully understood and warrants further investigation.